Physician profile
Peter Sonjoy Macfield
NPI 1831311778
$4,246.11
in general payments reported to CMS, 2019-2025
38 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $446 · 2021: $891 · 2022: $903 · 2023: $705 · 2024: $520 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $678.85 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $591.84 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $357.63 | 2019-2022 | |
| Astellas Pharma US INC | $286.31 | 2019-2024 | Veozah |
| Merck Sharp & Dohme LLC | $271.80 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Ironwood Pharmaceuticals, INC | $219.19 | 2021-2024 | Linzess |
| Astrazeneca Pharmaceuticals LP | $190.51 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $174.30 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.08 | 2019-2025 | Xifaxan |
| Lilly USA, LLC | $132.83 | 2019-2025 | Mounjaro, Zepbound |
| Kaleo, INC. | $114.89 | 2019-2022 | |
| Sanofi Pasteur INC. | $112.19 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $102.68 | 2022-2024 | Eliquis |
| Antares Pharma, INC. | $97.98 | 2020-2024 | Xyosted, Nocdurna, Tlando |
| Cranial Technologies, INC | $91.35 | 2022-2024 | Doc Band |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Macfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.